Cargando…

Effects of Antipsychotics on Bone Mineral Density in Patients with Schizophrenia: Gender Differences

Low bone mineral density (BMD) and osteoporosis are common in patients with schizophrenia and detrimental to illness prognosis and life quality. Although the pathogenesis is not fully clear, series of studies have revealed factors related to low BMD such as life style, psychotic symptoms, medication...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Chien-Yu, Lane, Hsien-Yuan, Lin, Chieh-Hsin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean College of Neuropsychopharmacology 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4977815/ https://www.ncbi.nlm.nih.gov/pubmed/27489377 http://dx.doi.org/10.9758/cpn.2016.14.3.238

Ejemplares similares

Long-term Use of Clozapine is Protective for Bone Density in Patients with Schizophrenia
por: Lin, Chieh-Hsin, et al.
Publicado: (2019)

Gender differences in bone mineral density in patients with sporadic primary hyperparathyroidism
por: Vodopivec, Danica M., et al.
Publicado: (2018)

Air Pollutants Interaction and Gender Difference on Bone Mineral Density T-Score in Taiwanese Adults
por: Lin, Yu-Hsuan, et al.
Publicado: (2020)

S219. RISK FACTORS FOR LOW BONE MINERAL DENSITY IN PATIENTS TAKING ANTIPSYCHOTICS
por: Jhon, Min, et al.
Publicado: (2018)

Gender Differences in the First-Year Antipsychotic Treatment for Chinese First-Episode Schizophrenia
por: Pu, Chengcheng, et al.
Publicado: (2020)

Factors associated with decreased bone mineral density in postmenopausal women with schizophrenia
por: Liang, Ying, et al.
Publicado: (2016)

D2 dopamine receptor gene (DRD2) Taq1A (rs1800497) affects bone density
por: Chiang, Ting-I., et al.
Publicado: (2020)

Bone Density in Chronic Schizophrenia with Long-Term Antipsychotic Treatment: Preliminary Study
por: Lee, Tae-Young, et al.
Publicado: (2010)

Early Identification and Intervention of Schizophrenia: Insight From Hypotheses of Glutamate Dysfunction and Oxidative Stress
por: Lin, Chieh-Hsin, et al.
Publicado: (2019)

d-Amino Acids and pLG72 in Alzheimer’s Disease and Schizophrenia
por: Cheng, Yu-Jung, et al.
Publicado: (2021)

Cystine/Glutamate Antiporter in Schizophrenia: From Molecular Mechanism to Novel Biomarker and Treatment
por: Hung, Chung-Chieh, et al.
Publicado: (2021)

Effects of Olanzapine on Bone Mineral Density, Glucose, and Lipid Metabolism in Schizophrenia Patients
por: Liang, Mining, et al.
Publicado: (2019)

Medications Used for Cognitive Enhancement in Patients With Schizophrenia, Bipolar Disorder, Alzheimer’s Disease, and Parkinson’s Disease
por: Hsu, Wen-Yu, et al.
Publicado: (2018)

Serum Prolactin and Bone Mineral Density in Schizophrenia: A Systematic Review
por: Lally, John, et al.
Publicado: (2019)

Association between Obesity and Bone Mineral Density by Gender and Menopausal Status
por: Salamat, Mohammad Reza, et al.
Publicado: (2016)

Implications of gender-based variabilities in bone mineral density and hemoglobin levels
por: Zhou, Yumei, et al.
Publicado: (2021)

Applying a bagging ensemble machine learning approach to predict functional outcome of schizophrenia with clinical symptoms and cognitive functions
por: Lin, Eugene, et al.
Publicado: (2021)

Prediction of functional outcomes of schizophrenia with genetic biomarkers using a bagging ensemble machine learning method with feature selection
por: Lin, Eugene, et al.
Publicado: (2021)

Polymorphism in the LASP1 gene promoter region alters cognitive functions of patients with schizophrenia
por: Lin, Chieh-Hsin, et al.
Publicado: (2019)

Different associations between waist circumference and bone mineral density stratified by gender, age, and body mass index
por: Yin, Zhiqiang, et al.
Publicado: (2022)

Genetic Effects of DISC1 and G72 (DAOA) on Visual Learning of Patients with Schizophrenia
por: Chang, Jane Pei-Chen, et al.
Publicado: (2020)

An Ensemble Approach to Predict Schizophrenia Using Protein Data in the N-methyl-D-Aspartate Receptor (NMDAR) and Tryptophan Catabolic Pathways
por: Lin, Eugene, et al.
Publicado: (2020)

Effects of vegetarian diet on bone mineral density
por: Chuang, Tzyy-Ling, et al.
Publicado: (2020)

Integrative genomic analysis for the functional roles of ITPKC in bone mineral density
por: Lu, Hsing-Fang, et al.
Publicado: (2018)

OR13-4 Bone Mineral Density in Transgender Youth on Gender Affirming Therapies
por: Ma, Nina, et al.
Publicado: (2022)

PICK1 Genetic Variation and Cognitive Function in Patients with Schizophrenia
por: Chen, Yi-Ting, et al.
Publicado: (2017)

Use of antipsychotic medication and its relationship with bone mineral density: A population-based study of men and women
por: Azimi Manavi, Behnaz, et al.
Publicado: (2023)

PM405. Sodium Benzoate Add-on Treatment for Refractory Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Trial
por: Lin, Chieh-Hsin, et al.
Publicado: (2016)

Increased Serum Leptin Level Predicts Bone Mineral Density in Hemodialysis Patients
por: Wang, Chih-Hsien, et al.
Publicado: (2020)

Association of bone mineral density and depression in different bone sites and ages: A meta‐analysis
por: Yuan, Shiyi, et al.
Publicado: (2021)

C-reactive protein is associated with severity of thought and language dysfunction in patients with schizophrenia
por: Chang, Chun-Hung, et al.
Publicado: (2019)

Serum Irisin Level Is Positively Associated with Bone Mineral Density in Patients on Maintenance Hemodialysis
por: Lu, Chia-Wen, et al.
Publicado: (2021)

Combination of G72 Genetic Variation and G72 Protein Level to Detect Schizophrenia: Machine Learning Approaches
por: Lin, Eugene, et al.
Publicado: (2018)

Acute weight gain, gender, and therapeutic response to antipsychotics in the treatment of patients with schizophrenia
por: Ascher-Svanum, Haya, et al.
Publicado: (2005)

Effects of Resveratrol on Bone Mineral Density in Ovarectomized Rats
por: Lin, Qian, et al.
Publicado: (2005)

Bone Mineral Density in Schizophrenia: An Update of Current Meta-Analysis and Literature Review Under Guideline of PRISMA
por: Tseng, Ping-Tao, et al.
Publicado: (2015)

Hypercoagulable state in patients with schizophrenia: different effects of acute and chronic antipsychotic medications
por: Zheng, Caiji, et al.
Publicado: (2023)

The causal effect of schizophrenia on fractures and bone mineral density: a comprehensive two-sample Mendelian randomization study of European ancestry
por: Jia, Ningning, et al.
Publicado: (2023)

Gender differences in the use of atypical antipsychotics in early-onset schizophrenia: a nationwide population-based study in Brazil
por: Fulone, Izabela, et al.
Publicado: (2021)

Effects of Long-Term Combination Treatment with Valproate and Atypical Antipsychotics on Bone Mineral Density and Bone Metabolism in Premenopausal Patients with Bipolar Disorder: A Preliminary Study
por: Yang, Jaewon, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_5bqr5f5thpnb73v31ikei1uqe6